Cyclophosphamide and prednisone induction followed by cyclophosphamide mobilization effectively decreases the incidence of engraftment syndrome in patients with POEMS syndrome who undergo stem cell transplantation

American Journal of Hematology

Volumn 86, Issue 10, 2011, Pages 873-875

  Jimenez Zepeda, Victor H ^a   Trudel, Suzanne ^a   Reece, Donna E ^a   Chen, Christine ^a   Rabea, Ahmed M ^a   Kukreti, Vishal ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; PREDNISONE;

ADULT; AGED; ANTIBIOTIC THERAPY; APHERESIS; AUTOLOGOUS STEM CELL TRANSPLANTATION; CLINICAL ARTICLE; DIARRHEA; ENGRAFTMENT SYNDROME; FEASIBILITY STUDY; FEMALE; FEVER; HUMAN; LETTER; MALE; MORBIDITY; MORTALITY; MUCOSA INFLAMMATION; ORAL MUCOSITIS; POEMS SYNDROME; PRIORITY JOURNAL; RASH; STEM CELL MOBILIZATION; TREATMENT OUTCOME; WEIGHT GAIN;

ADULT; AGED; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; MALE; MIDDLE AGED; POEMS SYNDROME; PREDNISONE; RETROSPECTIVE STUDIES; RISK FACTORS; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS;

EID: 80052893339     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.22115     Document Type: Letter

References (21)

1. Jimenez Zepeda VFN, Delgado D, Winter A, et al. High-dose melphalan for AL amyloidosis: The importance of case selection to improve clinical outcomes. Blood 2010; 116: 2403.
2. Gertz MA, Comenzo R, Falk RH, et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol 2005; 79: 319-328.
3. Gherardi RK, Chouaib S, Malapert D, et al. Early weight loss and high serum tumor necrosis factor-alpha levels in polyneuropathy, organomegaly, endocrinopathy, M protein, skin changes syndrome. Ann Neurol 1994; 35: 501-505.
4. Gattinoni L, Powell DJJr, Rosenberg SA, Restifo NP. Adoptive immunotherapy for cancer: Building on success. Nat Rev Immunol 2006; 6: 383-393.
5. Salem ML, Diaz-Montero CM, Al-Khami AA, et al. Recovery from cyclophosphamide-induced lymphopenia results in expansion of immature dendritic cells which can mediate enhanced prime-boost vaccination antitumor responses in vivo when stimulated with the TLR3 agonist poly(I:C). J Immunol 2009; 182: 2030-2040.
6. Salem ML, Cole DJ. Dendritic cell recovery post-lymphodepletion: A potential mechanism for anti-cancer adoptive T cell therapy and vaccination. Cancer Immunol Immunother 2010; 59: 341-353.
7. Salem ML, El-Naggar SA, Cole DJ. Cyclophosphamide induces bone marrow to yield higher numbers of precursor dendritic cells in vitro capable of functional antigen presentation to T cells in vivo. Cell Immunol 2010; 261: 134-143.
8. Vuckovic S, Kim M, Khalil D, et al. Granulocyte-colony stimulating factor increases CD123hi blood dendritic cells with altered CD62L and CCR7 expression. Blood 2003; 101: 2314-2317.
9. Dispenzieri A, Lacy MQ, Hayman SR, et al. Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome. Eur J Haematol 2008; 80: 397-406.
10. Dispenzieri A. POEMS syndrome. Hematology Am Soc Hematol Educ Program 2005: 360-367.
11. Spitzer TR. Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 893-898.
12. Maiolino A, Biasoli I, Lima J, Portugal AC, Pulcheri W, Nucci M. Engraftment syndrome following autologous hematopoietic stem cell transplantation: Definition of diagnostic criteria. Bone Marrow Transplant 2003; 31: 393-397.
13. Capizzi SA, Kumar S, Huneke NE, et al. Peri-engraftment respiratory distress syndrome during autologous hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 1299-1303.
14. Chen F, Zhang K, Tan X, et al. Autologous peripheral blood stem cell transplantation in a patient with POEMS syndrome. Ann Hematol 2008; 87: 247-248.
15. Diaz-Betancur J, Cuervo-Sierra J, Guzman-Zapata A, et al. Autologous peripheral blood stem cell transplantation in a patient with POEMS syndrome. Hematol Oncol Stem Cell Ther 2009; 2: 305-307.
16. Abrisqueta P, Rovira M, Cibeira MT, et al. Autologous haematopoietic stem cell transplantation in POEMS syndrome: Results in 4 cases. Med Clin (Barc) 2007; 129: 578-581.
17. Dispenzieri A, Moreno-Aspitia A, Suarez GA, et al. Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature. Blood 2004; 104: 3400-3407.
18. Gupta S, Rana V, Chandra D, et al. Autologous peripheral stem cell transplant for POEMS syndrome: A case report. Hematology 2006; 11: 361-363.
19. Hogan WJ, Lacy MQ, Wiseman GA, et al. Successful treatment of POEMS syndrome with autologous hematopoietic progenitor cell transplantation. Bone Marrow Transplant 2001; 28: 305-309.
20. Jaccard A, Royer B, Bordessoule D, et al. High-dose therapy and autologous blood stem cell transplantation in POEMS syndrome. Blood 2002; 99: 3057-3059.
21. Rabinowitz J, Petros WP, Stuart AR, Peters WP. Characterization of endogenous cytokine concentrations after high-dose chemotherapy with autologous bone marrow support. Blood 1993; 81: 2452-2459.